{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:08:48Z","timestamp":1768266528623,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1989,12]]},"DOI":"10.1378\/chest.96.6.1233","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T13:25:26Z","timestamp":1194441926000},"page":"1233-1236","source":"Crossref","is-referenced-by-count":13,"title":["Administration of Dopexamine, A New Adrenergic Agent, in Cardiorespiratory Failure"],"prefix":"10.1016","volume":"96","author":[{"given":"Jean-Louis","family":"Vincent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Reuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.96.6.1233_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1476-5381.1985.tb10554.x","article-title":"Dopexamine: a novel agonist at peripheral dopamine receptors and beta-2-adrenoceptors","volume":"85","author":"Brown","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1378\/chest.96.6.1233_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1985.tb10555.x","article-title":"The effects of dopexamine on the cardiovascular system of the dog","volume":"85","author":"Brown","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1378\/chest.96.6.1233_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1476-5381.1987.tb11320.x","article-title":"Inhibition of uptake 1 by dopexamine hydrochloride in vitro","volume":"92","author":"Mitchell","year":"1987","journal-title":"Br J Pharmacol"},{"key":"10.1378\/chest.96.6.1233_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2125.1986.tb05213.x","article-title":"The haemodynamic and myocardial effects of dopexamine: a new beta-2-adrenoceptor and dopaminergic agonist","volume":"21","author":"Jaski","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.96.6.1233_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/hrt.54.3.313","article-title":"Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure","volume":"54","author":"Dawson","year":"1985","journal-title":"Br Heart J"},{"key":"10.1378\/chest.96.6.1233_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0002-9149(88)91371-9","article-title":"Cardiovascular pharmacology of dopexamine in low output congestive heart failure","volume":"62","author":"Leier","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.96.6.1233_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00005344-198709000-00005","article-title":"Beneficial hemodynamic effects of intravenous dopexamine in patients with low-output heart failure","volume":"10","author":"Tan","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.96.6.1233_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/oxfordjournals.eurheartj.a062125","article-title":"Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure","volume":"7","author":"Svensson","year":"1986","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.96.6.1233_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00005344-198705000-00008","article-title":"Poole-Wilson P Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril and nitrate","volume":"9","author":"Bayliss","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.96.6.1233_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/oxfordjournals.eurheartj.a062536","article-title":"Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure","volume":"9","author":"Baumann","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.96.6.1233_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/oxfordjournals.eurheartj.a062578","article-title":"Dopexamine hydrochloride, a beta-2 adrenergic and dopaminergic agonist: hemodynamic effects following cardiac surgery","volume":"9","author":"Hakim","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.96.6.1233_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0883-9441(89)90090-7","article-title":"Increase in oxygen supply during experimental septic shock: the effects of dobutamine versus dopexamine","volume":"4","author":"Preiser","year":"1989","journal-title":"J Crit Care"},{"key":"10.1378\/chest.96.6.1233_bib13","first-page":"113","article-title":"Timing of cardiac output measurements during mechanical ventilation","volume":"12","author":"Daper","year":"1986","journal-title":"Acute Care"},{"key":"10.1378\/chest.96.6.1233_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00256775","article-title":"Dopexamine hydrochloride, a novel drug with renal vasodilator properties: two case studies","volume":"14","author":"Bodenham","year":"1988","journal-title":"Intensive Care Med"},{"key":"10.1378\/chest.96.6.1233_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00003246-198206000-00007","article-title":"Comparison of the effects of dobutamine, dopamine and isoproterenol on hypoxic pulmonary vasoconstriction in the pig","volume":"10","author":"Furman","year":"1982","journal-title":"Crit Care Med"},{"key":"10.1378\/chest.96.6.1233_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/hrt.60.1.45","article-title":"Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure","volume":"60","author":"Murphy","year":"1988","journal-title":"Br Heart J"},{"key":"10.1378\/chest.96.6.1233_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/hrt.60.6.489","article-title":"Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion","volume":"60","author":"Svenson","year":"1988","journal-title":"Br Heart J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921639314X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921639314X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T22:56:51Z","timestamp":1546469811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921639314X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["S001236921639314X"],"URL":"https:\/\/doi.org\/10.1378\/chest.96.6.1233","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1989,12]]}}}